Company Filing History:
1 out of 1,209 
1 out of 443 
1 out of 8,373 
Years Active: 2024
Title: Linglin Huang: Innovator in Cancer Immunotherapy
Introduction
Linglin Huang is a prominent inventor based in Boston, MA, known for his significant contributions to cancer research and immunotherapy. His work focuses on enhancing anti-tumor immunity through innovative methods and compositions that modulate cell interactions within the tumor microenvironment.
Latest Patents
Huang holds a patent titled "Methods and compositions for the modulation of cell interactions and signaling in the tumor microenvironment." This invention aims to identify interacting cells in the tumor microenvironment and utilize these interactions to boost anti-tumor immunity in cancer patients. The patent outlines how identified interactions can be modulated using therapeutic agents, and it emphasizes the use of immune cells resistant to suppression for adoptive cell transfer. Additionally, the invention addresses cell types and genes correlated with tumor growth and size.
Career Highlights
Throughout his career, Linglin Huang has worked with esteemed organizations such as Dana-Farber Cancer Institute and The Broad Institute. His research has significantly advanced the understanding of cancer biology and therapeutic strategies.
Collaborations
Huang has collaborated with notable colleagues, including Meromit Singer and Aviv Regev, contributing to a rich exchange of ideas and research advancements in the field of cancer immunotherapy.
Conclusion
Linglin Huang's innovative work in cancer research exemplifies the potential of targeted therapies to improve patient outcomes. His contributions continue to shape the future of cancer treatment and immunotherapy.